> c-Kit / CD117 Protein & Antibody c-Kit / CD117 Protein & Antibody
Cluster of Differentiation 117
c-Kit / CD117 Products
c-Kit / CD117 Protein, Recombinant
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| c-Kit/CD117 | Human | c-kit/CD117 Protein, Recombinant![]() |
11996-H08H |
| c-Kit/CD117 | Human | KIT / c-KIT / CD117 (aa 540-972) Protein, Recombinant, GST Tag | 11996-H20B1 |
| c-Kit/CD117 | Mouse | c-kit/CD117/Fc Protein, Recombinant![]() |
50530-M02H |
| c-Kit/CD117 | Mouse | c-kit/CD117 Protein, Recombinant![]() |
50530-M08H |
c-Kit / CD117 Antibody
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human c-Kit/CD117 | WB, ELISA | c-Kit / CD117 / KIT Antibody (Antigen Affinity Purified) | 11996-RP02 |
| Mouse c-Kit/CD117 | WB, ELISA | c-Kit / CD117 / KIT Antibody | 50530-RP01 |
| Mouse c-Kit/CD117 | WB, ELISA | c-Kit / CD117 / KIT Antibody (Antigen Affinity Purified) | 50530-RP02 |
c-Kit / CD117 cDNA Clone
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| c-Kit/CD117 | Human | Home sapiens c-kit/CD117 cDNA Clone | HG11996-G |
| c-Kit/CD117 | Mouse | Mus musculus c-kit/CD117 cDNA Clone | MG50530-M |
| c-Kit/CD117 | Rat | KIT cDNA Clone / ORF Clone | RG80321-G |
c-Kit / CD117 Related Areas
Stem Cell>>Hematopoietic Stem Cell (HSC)>>Hematopoietic Stem Cell Marker>>c-Kit/CD117
Immunology>>Cluster of Differentiation>>Hematopoietic Stem Cell CD Marker>>c-Kit/CD117
Cancer>>Growth Factor & Receptor>>Receptor Tyrosine Kinase>>c-Kit/CD117
Enzyme>>Protein Kinase>>Receptor Tyrosine Kinase>>c-Kit/CD117
Signal Transduction>>Protein Kinase>>Receptor Tyrosine Kinase>>c-Kit/CD117
c-Kit / CD117 Alternative Names
c-Kit, CD117, PBT, SCFR [Homo sapiens]
c-KIT, CD117, SCFR, Bs, Fdc, Gsfsco1, Gsfsco5, Gsfsow3, SCO1, SCO5, SOW3, Ssm, Tr-kit, W [Mus musculus]
c-Kit / CD117 Background
C-Kit is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). c-Kit contains 5 Ig-like C2-type (immunoglobulin-like) domains.and 1 protein kinase domain. It belongs to the protein kinase superfamily, tyr protein kinase family and CSF-1/PDGF receptor subfamily. C-Kit contains 5 Ig-like C2-type (immunoglobulin-like) domains and 1 protein kinase domain. C-Kit has a tyrosine-protein kinase activity. Binding of the ligands leads to the autophosphorylation of KIT and its association with substrates such as phosphatidylinositol 3-kinase. Antibodies to c-Kit are widely used in immunohistochemistry to help distinguish particular types of tumour in histological tissue sections. It is used primarily in the diagnosis of GISTs. In GISTs, c-Kit staining is typically cytoplasmic, with stronger accentuation along the cell membranes. C-Kit antibodies can also be used in the diagnosis of mast cell tumours and in distinguishing seminomas from embryonal carcinomas. Mutations in c-Kit gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Defects in KIT are a cause of acute myelogenous leukemia (AML). AML is a malignant disease in which hematopoietic precursors are arrested in an early stage of development. Note=Somatic mutations that lead to constitutive activation of KIT are detected in AML patients.
c-Kit / CD117 Related Studies
- Andre C, et al. (1997) Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics. 39(2):216-26.
- Yarden Y, et al. (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6(11):3341-51.
- Leong KG, et al. (2008) Generation of a prostate from a single adult stem cell. Nature. 456(7223): 804-8.
- Edling CE, et al. (2007) c-Kit--a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol. 39(11):1995-8.
- McIntyre A, et al. (2005) Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res. 65(18):8085-9.
+86-400-890-9989




